Certified by Founder
Lodge
AAVantgarde Bio
start up
Italy
- Milan, Lombardy
- 07/06/2023
- Series A
- $65,333,745
Delivering the next generation gene therapies
- Industry Biotechnology Research
- Website https://www.aavantgardebio.com/
- LinkedIn https://www.linkedin.com/company/aavantgarde-bio/
Related People
Natalia Misciattelli Mocenigo SoranzoFounder
United Kingdom -
Victoria, England
A well-rounded Biotech business executive with a proven track record of delivering shareholder value internationally.
Science and finance background combined with a passion for working in cutting edge technology. Creative thinker with expertise in generating and executing strategies to deliver company growth.
Experienced in building and leading teams through complex growth and transformation whilst managing multiple stakeholder groups in a fast pace evolving landscape. Strong leader skilled at building strategic relationships to drive opportunities and change in organizations.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)